Valentini, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 33.180
EU - Europa 22.862
AS - Asia 22.035
SA - Sud America 4.189
Continente sconosciuto - Info sul continente non disponibili 1.507
AF - Africa 712
OC - Oceania 93
Totale 84.578
Nazione #
US - Stati Uniti d'America 32.097
SG - Singapore 10.133
DE - Germania 7.000
CN - Cina 4.729
SE - Svezia 4.029
BR - Brasile 3.415
IT - Italia 2.973
VN - Vietnam 2.002
FR - Francia 1.940
UA - Ucraina 1.397
IN - India 1.247
IE - Irlanda 1.054
GB - Regno Unito 1.035
ID - Indonesia 724
FI - Finlandia 698
CA - Canada 572
PL - Polonia 569
JP - Giappone 565
NL - Olanda 560
RU - Federazione Russa 506
HK - Hong Kong 480
BD - Bangladesh 422
TR - Turchia 379
AR - Argentina 274
MX - Messico 272
IQ - Iraq 233
BE - Belgio 202
AT - Austria 184
ZA - Sudafrica 179
CZ - Repubblica Ceca 149
ES - Italia 145
PK - Pakistan 142
CI - Costa d'Avorio 135
EC - Ecuador 115
KR - Corea 108
SA - Arabia Saudita 107
IR - Iran 95
MA - Marocco 87
CO - Colombia 85
PH - Filippine 85
VE - Venezuela 85
AU - Australia 73
JO - Giordania 73
UZ - Uzbekistan 73
CL - Cile 68
CH - Svizzera 66
EG - Egitto 61
JM - Giamaica 55
LT - Lituania 52
KE - Kenya 51
IL - Israele 48
TN - Tunisia 47
AE - Emirati Arabi Uniti 46
PE - Perù 46
PY - Paraguay 38
MY - Malesia 37
UY - Uruguay 37
AZ - Azerbaigian 36
RO - Romania 36
KZ - Kazakistan 33
DZ - Algeria 32
NP - Nepal 29
CR - Costa Rica 28
PT - Portogallo 28
AL - Albania 27
GR - Grecia 26
TT - Trinidad e Tobago 24
OM - Oman 23
SN - Senegal 23
BO - Bolivia 22
EU - Europa 22
PA - Panama 22
HN - Honduras 21
NO - Norvegia 21
DK - Danimarca 20
DO - Repubblica Dominicana 20
RS - Serbia 20
TH - Thailandia 20
BG - Bulgaria 17
NZ - Nuova Zelanda 16
ET - Etiopia 15
KG - Kirghizistan 15
LK - Sri Lanka 15
NI - Nicaragua 15
TW - Taiwan 15
AM - Armenia 14
LB - Libano 14
LV - Lettonia 14
NG - Nigeria 14
BH - Bahrain 13
BB - Barbados 12
BY - Bielorussia 12
GE - Georgia 11
HR - Croazia 11
MD - Moldavia 11
QA - Qatar 11
SK - Slovacchia (Repubblica Slovacca) 11
SY - Repubblica araba siriana 11
A2 - ???statistics.table.value.countryCode.A2??? 10
LU - Lussemburgo 10
Totale 82.899
Città #
Singapore 5.553
Chandler 4.008
Ashburn 3.011
San Jose 2.793
Beijing 1.056
Dublin 1.046
New York 995
Los Angeles 933
Jacksonville 833
San Mateo 758
Ho Chi Minh City 666
Ann Arbor 634
Jakarta 631
The Dalles 605
Lauterbourg 591
Milan 559
Wilmington 529
Frankfurt am Main 523
Nanjing 510
Hanoi 502
Rome 488
Tokyo 487
Warsaw 484
Munich 436
Amsterdam 426
Hong Kong 426
Boston 410
Woodbridge 378
Hyderabad 361
Hefei 355
Dearborn 348
Houston 322
São Paulo 320
Dallas 293
Princeton 293
Moscow 292
Chicago 287
Nürnberg 285
Helsinki 274
Fairfield 271
Marseille 266
Lawrence 247
Bremen 244
Buffalo 234
Santa Clara 233
Cattolica 232
Izmir 220
Seattle 220
Redwood City 200
Brussels 197
Council Bluffs 180
Toronto 177
Atlanta 176
Nanchang 176
St Louis 160
Boardman 158
Zhengzhou 158
Abidjan 135
Orem 133
Brooklyn 132
London 132
Paris 116
Montreal 114
Nuremberg 113
Da Nang 109
Shanghai 109
Vienna 106
Johannesburg 99
Turku 97
Seoul 93
Shenyang 92
Denver 91
Leawood 91
Phoenix 90
Tianjin 89
Washington 89
Rio de Janeiro 87
Kunming 86
Augusta 85
Haiphong 85
Kent 85
Pune 83
Detroit 82
Norwalk 82
Stockholm 82
Memphis 81
San Francisco 80
Mexico City 79
Düsseldorf 77
Guangzhou 75
Jiaxing 74
Hebei 73
Belo Horizonte 72
Cambridge 72
Chennai 72
Hangzhou 71
Mountain View 69
Brno 68
Amman 67
University Park 66
Totale 41.333
Nome #
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 1.003
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 524
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 381
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 373
Combined-modality therapy in locally advanced primary rectal cancer 356
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 349
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 336
Artificial intelligence to predict individualized outcome of acute ischemic stroke patients: The SIBILLA project 328
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 319
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 312
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 306
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 302
Art and digital technologies to support resilience during the oncological journey: The Art4ART project 300
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 299
Modelling tumour volume variations in head and neck cancer: magnetic resonance imaging contribution for patients undergoing induction chemotherapy 298
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 298
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 292
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort 288
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 284
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 273
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 272
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 269
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 267
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 257
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). 252
Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: Is there a place for critical swallowing structures dose sparing? 247
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 238
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer after Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome 237
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 233
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 233
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 230
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 230
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 228
Allies not enemies—creating a more empathetic and uplifting patient experience through technology and art 228
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 227
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 226
Gender role in radiotherapy: psychosocial differences between males and females during cancer care: Single-centre report on adult and paediatric oncological patients 225
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 225
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 220
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 220
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 219
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 219
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 217
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 216
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 213
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 213
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 211
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 208
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 207
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 207
A real-time integrated framework to support clinical decision making for covid-19 patients 205
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 204
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 202
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 201
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 200
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 200
Neoadjuvant radiochemotherapy and perioperative chemotherapy do not represent a standard at the same priority level for esophageal adenocarcinomas (with regard to 'Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up') 199
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 199
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 198
A Machine Learning Predictive Model of Bloodstream Infection in Hospitalized Patients 197
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 197
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 197
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 197
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 196
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 196
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 196
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 194
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 194
Experimental evaluation of the impact of low tesla transverse magnetic field on dose distribution in presence of tissue interfaces 194
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 193
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 193
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 193
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 193
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 189
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 189
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 187
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 186
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 186
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 185
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 185
Multiple abscesses in a patient treated with cetuximab 185
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 184
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 184
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 184
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 183
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 182
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 182
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 182
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 181
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer 180
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 179
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study) 179
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 178
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 178
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 177
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 177
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 176
Totale 24.323
Categoria #
all - tutte 350.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 350.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.752 0 307 103 411 252 171 80 723 232 348 1.135 990
2022/202311.225 1.570 1.538 869 1.747 675 1.314 566 874 1.249 240 412 171
2023/20245.589 231 1.532 225 369 241 860 325 299 80 195 581 651
2024/202511.732 313 362 890 433 1.125 419 416 538 1.695 1.282 2.297 1.962
2025/202630.524 4.464 806 1.542 3.207 5.145 2.578 5.070 1.497 1.988 2.187 1.017 1.023
2026/20274.266 1.310 2.956 0 0 0 0 0 0 0 0 0 0
Totale 84.578